Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

neoadjuvant therapy

  • You have access
    Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer
    TATSUNARI FUKUOKA, KIYOSHI MAEDA, HISASHI NAGAHARA, MASATSUNE SHIBUTANI, YASUHITO ISEKI, SHINJI MATSUTANI, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research September 2019, 39 (9) 5157-5163; DOI: https://doi.org/10.21873/anticanres.13711
  • You have access
    Comparison of Minimally Invasive Surgery and Abdominal Surgery Among Patients With Cervical Cancer
    DOMINIK RATIU, CHRISTIAN LUNCESCU, BERND MORGENSTERN, CHRISTIAN EICHLER, BERTHOLD GRÜTTNER, SEBASTIAN LUDWIG, PETER MALLMANN and FABINSHY THANGARAJAH
    Anticancer Research May 2019, 39 (5) 2661-2664; DOI: https://doi.org/10.21873/anticanres.13390
  • You have access
    Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy
    NICCOLÒ PETRUCCIANI, MARIA CLOTILDE CARRA, ALEIX MARTÍNEZ-PÉREZ, GIULIO CESARE VITALI, FILIPPO LANDI, PIETRO GENOVA, RICCARDO MEMEO, FRANCESCO BRUNETTI, ELOY ESPIN, FREDERIC RIS, NICOLA DE'ANGELIS and on behalf of the EUMARCS Study Group
    Anticancer Research April 2019, 39 (4) 2113-2120; DOI: https://doi.org/10.21873/anticanres.13324
  • You have access
    Outcome of Trimodal Therapy in Elderly Patients with Esophageal Cancer: Prognostic Value of the Charlson Comorbidity Index
    DANIELE BERNARDI, EMANUELE ASTI, ALBERTO AIOLFI, GIANLUCA BONITTA, ALBERTO LUPORINI and LUIGI BONAVINA
    Anticancer Research March 2018, 38 (3) 1815-1820;
  • You have access
    Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors
    MANABU KANEKO, HIROAKI NOZAWA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI, KENSUKE OTANI, TAKESHI NISHIKAWA, TOSHIAKI TANAKA, TOMOMICHI KIYOMATSU, KEISUKE HATA, KAZUSHIGE KAWAI and TOSHIAKI WATANABE
    Anticancer Research September 2017, 37 (9) 5155-5160;
  • You have access
    A Phase II Trial of Two Durations of Bevacizumab Added to Neoadjuvant Gemcitabine for Borderline and Locally Advanced Pancreatic Cancer
    KLAUS SAHORA, MARTIN SCHINDL, IRENE KUEHRER, AXEL EISENHUT, GREGOR WERBA, CHRISTINE BROSTJAN, BELA TELEK, AHMED BA'SSALAMAH, JUDITH STIFT, SEBASTIAN F. SCHOPPMANN and MICHAEL GNANT
    Anticancer Research May 2014, 34 (5) 2377-2384;
  • You have access
    Long-term Results of Preoperative 5-Fluorouracil-Oxaliplatin Chemoradiation Therapy in Locally Advanced Rectal Cancer
    ELISA FONTANA, FRANCESCA PUCCI, ROBERTA CAMISA, SIMONA BUI, SALVATORE GALDY, FRANCESCO LEONARDI, FRANCESCA VIRGINIA NEGRI, ELISA ANSELMI, PIER LUIGI LOSARDO, LUIGI RONCORONI, PAOLO DELL'ABATE, PELLEGRINO CRAFA, STEFANO CASCINU and ANDREA ARDIZZONI
    Anticancer Research February 2013, 33 (2) 725-730;

Pages

  • Previous
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire